乌鸦传媒

<乌鸦传媒 class="page-title">Meeting Coverage

ASCO Video Pearls: Bladder Cancer

<乌鸦传媒 class="page-description">Video Pearls from the American Society of Clinical Oncology
EphrinB2 Expression in Urothelial Cancer Tied to Checkpoint Inhibitor Activity

Retrospective data confirm EphrinB2 as a negative prognostic marker

image
<乌鸦传媒 class="section_title">Latest ASCO Video Pearls: Bladder Cancer Meeting Coverage
Add-On PD-L1 Inhibitor Promising in Muscle-Invasive Bladder Cancer

Neoadjuvant atezolizumab plus standard chemotherapy was safe and effective

July 8, 2021
Diving Deeper Into Benefit of Avelumab Maintenance in Bladder Cancer

Xin Gao summarizes three post hoc analyses from the JAVELIN Bladder 100 trial

June 24, 2021
New Bladder-Sparing Approaches Emerge at ASCO 2021

Matt Galsky discusses gemcitabine-cisplatin plus nivolumab for muscle-invasive bladder cancer

June 17, 2021
<乌鸦传媒 class="section_title"> Latest Oncology/Hematology Meeting Coverage